西方国家2型糖尿病早期的治疗药物选择.pptxVIP

Bj?rn EliassonSahlgrenska University hospital andUniversity of Gothenburg, SwedenEarly therapy and regimen choice for type 2 diabetes in Western patientsGood glucose-lowering treatment: requirementsEfficacious (glucose-lowering)Safecardiovascular outcome trialsFew side-effectsweighthypoglycaemiaReasonable priceExperience, scienceand priceOld pharmacologic agentsNew pharmacologic agentsExperienceLongShortSciencePoorSolidPriceLowHighCVOT - Cardiovascularoutcome trialDiabetes 2009;58:773–95. Available optionsMetforminSulfonylureaSGLT-2 inhibitorsDPP-4 inhibitorsGLP-1 receptor agonistsPioglitazone